Chancery Awards BioPharm Co. $38M For Fraud-Tainted Deal
A Takeda Pharmaceutical Co. subsidiary that sought $146 million in damages after Delaware's Chancery Court found fraud in a cancer drug development deal came away with a $38.2 million award Friday...To view the full article, register now.
Already a subscriber? Click here to view full article